Laboratory of Molecular Medicine, Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark.
Kidney Int. 2013 Sep;84(3):562-9. doi: 10.1038/ki.2013.195. Epub 2013 May 29.
Complement C4 is a central component of the classical and the lectin pathways of the complement system. The C4 protein exists as two isotypes C4A and C4B encoded by the C4A and C4B genes, both of which are found with varying copy numbers. Deposition of C4 has been implicated in kidney graft rejection, but a relationship between graft survival and serum C4 concentration as well as C4 genetic variation has not been established. We evaluated this using a prospective study design of 676 kidney transplant patients and 211 healthy individuals as controls. Increasing C4 gene copy numbers significantly correlated with the C4 serum concentration in both patients and controls. Patients with less than four total copies of C4 genes transplanted with a deceased donor kidney experienced a superior 5-year graft survival (hazard ratio 0.46, 95% confidence interval: 0.25-0.84). No significant association was observed in patients transplanted with a living donor. Thus, low C4 copy numbers are associated with increased kidney graft survival in patients receiving a kidney from a deceased donor. Hence, the degree of ischemia may influence the clinical impact of complement.
补体 C4 是补体系统经典途径和凝集素途径的核心组成部分。C4 蛋白有两种同型 C4A 和 C4B,由 C4A 和 C4B 基因编码,两者的拷贝数不同。C4 的沉积与肾移植排斥反应有关,但移植后血清 C4 浓度与 C4 遗传变异与移植物存活率之间的关系尚未确定。我们使用 676 例肾移植患者和 211 名健康个体作为对照的前瞻性研究设计来评估这一点。在患者和对照组中,C4 基因拷贝数的增加与 C4 血清浓度呈显著正相关。接受已故供体肾脏移植且 C4 基因拷贝数少于四个的患者,其 5 年移植物存活率更高(风险比 0.46,95%置信区间:0.25-0.84)。在接受活体供体移植的患者中未观察到显著相关性。因此,低 C4 拷贝数与接受已故供体肾脏的患者的移植物存活率增加有关。因此,缺血程度可能会影响补体的临床影响。